Stocks and Investing Stocks and Investing
Mon, December 27, 2021
Thu, December 23, 2021
Wed, December 22, 2021

Liisa Bayko Maintained (VRTX) at Buy and Held Target at $265 on, Dec 22nd, 2021


Published on 2024-10-27 19:05:03 - WOPRAI, Liisa Bayko
  Print publication without navigation


Liisa Bayko of Evercore ISI Group, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy and Held Target at $265 on, Dec 22nd, 2021.

Liisa has made no other calls on VRTX in the last 4 months.



There are 10 other peers that have a rating on VRTX. Out of the 10 peers that are also analyzing VRTX, 3 agree with Liisa's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Do Kim of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $218 on, Friday, November 19th, 2021
  • Evan Seigerman of "BMO Capital" Initiated at Hold and Held Target at $202 on, Friday, November 19th, 2021
  • Paul Matteis of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $213 on, Thursday, September 9th, 2021


These are the ratings of the 7 analyists that currently disagree with Liisa


  • Mohit Bansal of "Wells Fargo" Initiated at Buy and Held Target at $270 on, Thursday, December 9th, 2021
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $275 on, Thursday, December 2nd, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Increased Target to $265 on, Thursday, December 2nd, 2021
  • Brian Skorney of "Baird" Maintained at Buy and Held Target at $240 on, Thursday, December 2nd, 2021
  • Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $286 on, Wednesday, December 1st, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $341 on, Wednesday, December 1st, 2021
  • Matthew Harrison of "Morgan Stanley" Downgraded from Hold to Sell and Held Target at $202 on, Tuesday, September 7th, 2021
Contributing Sources